Ovarian Cancer

• CLINICAL_TRIALS trial_result · 2025-03-28
  Clinical Trial Update: Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation [Phase 2]

  Phase 2 trial evaluating bevacizumab and/or niraparib in patients with recurrent endometrial and/or ovarian cancer harboring ARID1A mutation…

• CLINICAL_TRIALS research · 2025-03-28
  Clinical Trial Update: A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL) [Phase 1, Phase 2]

  A Phase 1/2 clinical trial is evaluating the combination of niraparib with abemaciclib for late-line ovarian cancer and is currently recruit…

• CLINICAL_TRIALS trial_result · 2025-03-26
  Clinical Trial Update: Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece [NA]

  A completed clinical trial conducted in Greece assessed the implementation of Enhanced Recovery After Surgery pathways in major gynecologic …

• CLINICAL_TRIALS trial_result · 2025-03-26
  Clinical Trial Update: MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

  Phase 1 trial update of MOv19-BBz CAR T cells targeting aFR-expressing recurrent high-grade serous ovarian, fallopian tube, or primary perit…

• CLINICAL_TRIALS research · 2025-03-26
  Clinical Trial Update: Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.

  This clinical trial update evaluates ultrasound-guided Tru-cut biopsy in patients with suspected ovarian cancer to assess tissue adequacy, d…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-03-26
  Clinical Trial Update: Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer [NA]

  This clinical trial entry describes a recruiting study evaluating laparoscopic interval cytoreductive surgery for advanced ovarian cancer.

• CLINICAL_TRIALS research · 2025-03-24
  Clinical Trial Update: A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer [Phase 2]

  Phase 2 clinical study evaluating Fasudil Hydrochloride for gene-specific ovarian cancer is currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-03-21
  Clinical Trial Update: A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer [Phase 4]

  Phase 4 trial to evaluate the safety of Niraparib tablets in adult women with advanced or relapsed epithelial ovarian cancer; the study is n…

• CLINICAL_TRIALS trial_result · 2025-03-20
  Clinical Trial Update: QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer [Phase 4]

  Phase 4 trial comparing trabectedin plus pegylated liposomal doxorubicin versus platinum-based therapy in platinum-sensitive recurrent ovari…

• CLINICAL_TRIALS research · 2025-03-20
  Clinical Trial Update: Lipid Mediators & Cancer: Montelukast, SPM, and Almonds [EARLY_Phase 1]

  This early Phase 1 clinical trial from the University of South Florida investigates montelukast, specialized pro-resolving mediators, and al…

• CLINICAL_TRIALS trial_result · 2025-03-19
  Clinical Trial Update: Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery [NA]

  This completed clinical trial compared a single-dose tranexamic acid with placebo in ovarian cancer surgery to assess perioperative blood lo…

• CLINICAL_TRIALS research · 2025-03-19
  Clinical Trial Update: A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors [Phase 1, Phase 2]

  This clinical trial updates the investigation of DC05F01 in Chinese patients with recurrent or refractory ovarian cancer and other advanced …

• CLINICAL_TRIALS research · 2025-03-19
  Clinical Trial Update: METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating METR-NK cells in combination with anti-angiogenic neoadjuvant therapy for advanced epithelial ovarian ca…

• CLINICAL_TRIALS research · 2025-03-18
  Clinical Trial Update: Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer [Phase 2, Phase 3]

  Clinical trial investigating pegylated liposomal doxorubicin plus adebrelimab with or without mirabegron for relapsed ovarian cancer; Phase …

• CLINICAL_TRIALS trial_result · 2025-03-17
  Clinical Trial Update: A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors [Phase 1, Phase 2]

  Valerio Therapeutics terminated a Phase 1/2 trial of VIO-01 in patients with advanced or metastatic solid tumors, including breast, ovarian,…

• CLINICAL_TRIALS trial_result · 2025-03-14
  Clinical Trial Update: Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery [Phase 4]

  This Phase 4 clinical trial update describes using near-infrared fluorescence imaging with indocyanine green to evaluate bowel anastomoses i…

• CLINICAL_TRIALS trial_result · 2025-03-13
  Clinical Trial Update: Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]

  Clinical trial update of atezolizumab, guadecitabine, and CDX-1401 vaccine in recurrent platinum-resistant ovarian, fallopian tube, and prim…

• CLINICAL_TRIALS trial_result · 2025-03-13
  Clinical Trial Update: Spatial Radiogenomics of Ovarian Cancer

  A clinical trial titled Spatial Radiogenomics of Ovarian Cancer (NCT06324175) is currently recruiting, sponsored by Fondazione Policlinico U…

• CLINICAL_TRIALS research · 2025-03-12
  Clinical Trial Update: An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer [Phase 2]

  An exploratory, multi-cohort Phase II trial evaluating the combination of AK104 and AK112 for recurrent ovarian cancer is currently recruiti…

• CLINICAL_TRIALS research · 2025-03-12
  Clinical Trial Update: Mesenteric Infiltration in Ovarian Cancer

  A clinical trial investigating mesenteric infiltration in ovarian cancer is currently recruiting.

• CLINICAL_TRIALS research · 2025-03-12
  Clinical Trial Update: Prospective Evaluation of the Role of MRI in Ovarian Masses During Pregnancy

  A prospective study is evaluating the role of magnetic resonance imaging (MRI) in ovarian masses during pregnancy, sponsored by Fondazione P…

• CLINICAL_TRIALS trial_result · 2025-03-10
  Clinical Trial Update: Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer [Phase 4]

  A Phase IV multicenter trial of olaparib in Indian patients with ovarian cancer and metastatic breast cancer has completed and posted result…

• CLINICAL_TRIALS research · 2025-03-10
  Clinical Trial Update: Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer [Phase 3]

  A Phase 3 clinical trial evaluating paclitaxel lipid suspension for platinum-resistant or refractory ovarian cancer and related platinum-res…

• CLINICAL_TRIALS research · 2025-03-07
  Clinical Trial Update: Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer [Phase 2]

  Phase 2 clinical trial evaluating Taxol (paclitaxel) given intravenously and intraperitoneally with Tasigna (nilotinib) taken orally for per…

• CLINICAL_TRIALS trial_result · 2025-03-07
  Clinical Trial Update: BP1001-A in Patients With Advanced or Recurrent Solid Tumors [Phase 1]

  This clinical trial update states that BP1001-A is being evaluated in a Phase 1 study for advanced or recurrent solid tumors and is currentl…